Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes

Authors: Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Gemma Pujadas, Lucia La Sala, Loredana Bucciarelli, Maurizio Rondinelli, Stefano Genovese

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

It has been reported that hyperglycemia following hypoglycemia produces an ischemia-reperfusion-like effect in type 1 diabetes. In this study the possibility that GLP-1 has a protective effect on this phenomenon has been tested.

Methods

15 type 1 diabetic patients underwent to five experiments: a period of two hours of hypoglycemia followed by two hours of normo-glycemia or hyperglycemia with the concomitant infusion of GLP-1 or vitamin C or both. At baseline, after 2 and 4 hours, glycemia, plasma nitrotyrosine, plasma 8-iso prostaglandin F2alpha, sCAM-1a, IL-6 and flow mediated vasodilation were measured.

Results

After 2 h of hypoglycemia, flow mediated vasodilation significantly decreased, while sICAM-1, 8-iso-PGF2a, nitrotyrosine and IL-6 significantly increased. While recovering with normoglycemia was accompanied by a significant improvement of endothelial dysfunction, oxidative stress and inflammation, a period of hyperglycemia after hypoglycemia worsens all these parameters. These effects were counterbalanced by GLP-1 and better by vitamin C, while the simultaneous infusion of both almost completely abolished the effect of hyperglycemia post hypoglycemia.

Conclusions

This study shows that GLP-1 infusion, during induced hyperglycemia post hypoglycemia, reduces the generation of oxidative stress and inflammation, improving the endothelial dysfunction, in type 1 diabetes. Furthermore, the data support that vitamin C and GLP-1 may have an additive protective effect in such condition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wright RJ, Frier BM: Vascular disease and diabetes: is hypoglycaemia an aggravating factor?. Diabetes Metab Res Rev. 2008, 24: 353-363. 10.1002/dmrr.865.CrossRefPubMed Wright RJ, Frier BM: Vascular disease and diabetes: is hypoglycaemia an aggravating factor?. Diabetes Metab Res Rev. 2008, 24: 353-363. 10.1002/dmrr.865.CrossRefPubMed
2.
go back to reference Singh P, Jain A, Kaur G: Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem. 2004, 260: 153-159.CrossRefPubMed Singh P, Jain A, Kaur G: Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem. 2004, 260: 153-159.CrossRefPubMed
3.
go back to reference Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN: Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care. 2010, 33: 1529-1535. 10.2337/dc09-0354.PubMedCentralCrossRefPubMed Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN: Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care. 2010, 33: 1529-1535. 10.2337/dc09-0354.PubMedCentralCrossRefPubMed
4.
go back to reference Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, Gutterman DD, Widlansky ME: Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol. 2012, 32: 712-720. 10.1161/ATVBAHA.111.227389.PubMedCentralCrossRefPubMed Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, Gutterman DD, Widlansky ME: Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol. 2012, 32: 712-720. 10.1161/ATVBAHA.111.227389.PubMedCentralCrossRefPubMed
6.
go back to reference Ceriello A: Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes. Eur J Cardiovasc Prev Rehabil. 2010, 17 (Suppl 1): S15-S19.CrossRefPubMed Ceriello A: Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes. Eur J Cardiovasc Prev Rehabil. 2010, 17 (Suppl 1): S15-S19.CrossRefPubMed
7.
go back to reference Razavi Nematollahi L, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM, Gozashti MH, Omidfar K, Taheri E: Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009, 58: 443-448. 10.1016/j.metabol.2008.10.018.CrossRefPubMed Razavi Nematollahi L, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM, Gozashti MH, Omidfar K, Taheri E: Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009, 58: 443-448. 10.1016/j.metabol.2008.10.018.CrossRefPubMed
8.
go back to reference Nandish S, Wyatt J, Bailon O, Smith M, Oliveros R, Chilton R: Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus. Am J Cardiol. 2011, 108 (3 Suppl): 42B-51B.CrossRefPubMed Nandish S, Wyatt J, Bailon O, Smith M, Oliveros R, Chilton R: Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus. Am J Cardiol. 2011, 108 (3 Suppl): 42B-51B.CrossRefPubMed
9.
go back to reference Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA: Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest. 2007, 117: 910-918. 10.1172/JCI30077.PubMedCentralCrossRefPubMed Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA: Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest. 2007, 117: 910-918. 10.1172/JCI30077.PubMedCentralCrossRefPubMed
10.
go back to reference Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R, Bonfigli AR, Esposito K, Giugliano D: Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012, 61: 2993-2997. 10.2337/db12-0224.PubMedCentralCrossRefPubMed Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R, Bonfigli AR, Esposito K, Giugliano D: Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012, 61: 2993-2997. 10.2337/db12-0224.PubMedCentralCrossRefPubMed
11.
go back to reference Taegtmeyer H, Dilsizian V: Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Cardiovasc Med. 2008, 5 (Suppl 2): S42-S48.CrossRefPubMed Taegtmeyer H, Dilsizian V: Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Cardiovasc Med. 2008, 5 (Suppl 2): S42-S48.CrossRefPubMed
12.
go back to reference Peters A: Incretin-based therapies: review of current clinical trial data. Am J Med. 2010, 123 (Suppl. 3): S28-S37.CrossRefPubMed Peters A: Incretin-based therapies: review of current clinical trial data. Am J Med. 2010, 123 (Suppl. 3): S28-S37.CrossRefPubMed
13.
go back to reference Meier JJ, Nauck MA: Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?. Diabetes. 2010, 59: 1117-1125. 10.2337/db09-1899.PubMedCentralCrossRefPubMed Meier JJ, Nauck MA: Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?. Diabetes. 2010, 59: 1117-1125. 10.2337/db09-1899.PubMedCentralCrossRefPubMed
14.
go back to reference Issa CM, Azar ST: Possible role of GLP-1 and its agonists in the treatment of type 1 diabetes mellitus. Curr Diab Rep. 2012, 12: 560-567. 10.1007/s11892-012-0291-6.CrossRefPubMed Issa CM, Azar ST: Possible role of GLP-1 and its agonists in the treatment of type 1 diabetes mellitus. Curr Diab Rep. 2012, 12: 560-567. 10.1007/s11892-012-0291-6.CrossRefPubMed
15.
go back to reference Mudaliar S, Henry RR: Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function. Am J Med. 2010, 123 (Suppl. 3): S19-S27.CrossRefPubMed Mudaliar S, Henry RR: Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function. Am J Med. 2010, 123 (Suppl. 3): S19-S27.CrossRefPubMed
16.
go back to reference Nyström T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrén B, Sjöholm A: Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab. 2004, 287: E1209-E1215. 10.1152/ajpendo.00237.2004.CrossRefPubMed Nyström T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrén B, Sjöholm A: Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab. 2004, 287: E1209-E1215. 10.1152/ajpendo.00237.2004.CrossRefPubMed
17.
go back to reference Ceriello A, Esposito K, Testa R, Bonfigli AR, Marra M, Giugliano D: The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an “endothelial resistance” to glucagon-like peptide 1 in diabetes. Diabetes Care. 2011, 34: 697-702. 10.2337/dc10-1949.PubMedCentralCrossRefPubMed Ceriello A, Esposito K, Testa R, Bonfigli AR, Marra M, Giugliano D: The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an “endothelial resistance” to glucagon-like peptide 1 in diabetes. Diabetes Care. 2011, 34: 697-702. 10.2337/dc10-1949.PubMedCentralCrossRefPubMed
18.
go back to reference Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH: Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol. 2010, 30: 1407-1414. 10.1161/ATVBAHA.110.206425.CrossRefPubMed Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH: Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol. 2010, 30: 1407-1414. 10.1161/ATVBAHA.110.206425.CrossRefPubMed
19.
go back to reference Chinda K, Chattipakorn S, Chattipakorn N: Cardioprotective effects of incretin during ischaemia-reperfusion. Diab Vasc Dis Res. 2012, 9: 256-269. 10.1177/1479164112440816.CrossRefPubMed Chinda K, Chattipakorn S, Chattipakorn N: Cardioprotective effects of incretin during ischaemia-reperfusion. Diab Vasc Dis Res. 2012, 9: 256-269. 10.1177/1479164112440816.CrossRefPubMed
20.
go back to reference Green CJ, Henriksen TI, Pedersen BK, Solomon TP: Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia. PLoS One. 2012, 7: e44284-10.1371/journal.pone.0044284.PubMedCentralCrossRefPubMed Green CJ, Henriksen TI, Pedersen BK, Solomon TP: Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia. PLoS One. 2012, 7: e44284-10.1371/journal.pone.0044284.PubMedCentralCrossRefPubMed
21.
go back to reference Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993, 91: 301-307. 10.1172/JCI116186.PubMedCentralCrossRefPubMed Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993, 91: 301-307. 10.1172/JCI116186.PubMedCentralCrossRefPubMed
22.
go back to reference Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001, 44: 834-838. 10.1007/s001250100529.CrossRefPubMed Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001, 44: 834-838. 10.1007/s001250100529.CrossRefPubMed
23.
go back to reference Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP: Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004, 109: 962-965. 10.1161/01.CIR.0000120505.91348.58.CrossRefPubMed Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP: Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004, 109: 962-965. 10.1161/01.CIR.0000120505.91348.58.CrossRefPubMed
24.
go back to reference Birnbaum Y, Ye Y, Bajaj M: Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms. Metab Syndr Relat Disord. 2012, 10: 387-390. 10.1089/met.2012.0095.CrossRefPubMed Birnbaum Y, Ye Y, Bajaj M: Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms. Metab Syndr Relat Disord. 2012, 10: 387-390. 10.1089/met.2012.0095.CrossRefPubMed
25.
go back to reference Dokken BB, Piermarini CV, Teachey MK, Gura MT, Dameff CJ, Heller BD, Krate J, Ashgar AM, Querin L, Mitchell JL, Hilwig RW, Kern KB: Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects. Am J Physiol Heart Circ Physiol. 2013, 304: H538-H546. 10.1152/ajpheart.00282.2012.CrossRefPubMed Dokken BB, Piermarini CV, Teachey MK, Gura MT, Dameff CJ, Heller BD, Krate J, Ashgar AM, Querin L, Mitchell JL, Hilwig RW, Kern KB: Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects. Am J Physiol Heart Circ Physiol. 2013, 304: H538-H546. 10.1152/ajpheart.00282.2012.CrossRefPubMed
27.
go back to reference Tesauro M, Schinzari F, Adamo A, Rovella V, Martini F, Mores N, Barini A, Pitocco D, Ghirlanda G, Lauro D, Campia U, Cardillo C: Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the Metabolic Syndrome. Diabetes Care. 2013, 36: 683-689. 10.2337/dc12-0763.PubMedCentralCrossRefPubMed Tesauro M, Schinzari F, Adamo A, Rovella V, Martini F, Mores N, Barini A, Pitocco D, Ghirlanda G, Lauro D, Campia U, Cardillo C: Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the Metabolic Syndrome. Diabetes Care. 2013, 36: 683-689. 10.2337/dc12-0763.PubMedCentralCrossRefPubMed
28.
go back to reference Kelly AS, Bergenstal RM, Gonzalez-Campoy JM, Katz H, Bank AJ: Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial. Cardiovasc Diabetol. 2012, 11: 64-10.1186/1475-2840-11-64.PubMedCentralCrossRefPubMed Kelly AS, Bergenstal RM, Gonzalez-Campoy JM, Katz H, Bank AJ: Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial. Cardiovasc Diabetol. 2012, 11: 64-10.1186/1475-2840-11-64.PubMedCentralCrossRefPubMed
29.
30.
go back to reference Orchard TJ, Costacou T: When are type 1 diabetic patients at risk for cardiovascular disease?. Curr Diab Rep. 2010, 10: 48-54. 10.1007/s11892-009-0089-3.CrossRefPubMed Orchard TJ, Costacou T: When are type 1 diabetic patients at risk for cardiovascular disease?. Curr Diab Rep. 2010, 10: 48-54. 10.1007/s11892-009-0089-3.CrossRefPubMed
31.
go back to reference Gruden G, Barutta F, Chaturvedi N, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Cavallo Perin P, Bruno G: Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care. 2012, 35: 1598-1604. 10.2337/dc11-1531.PubMedCentralCrossRefPubMed Gruden G, Barutta F, Chaturvedi N, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Cavallo Perin P, Bruno G: Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care. 2012, 35: 1598-1604. 10.2337/dc11-1531.PubMedCentralCrossRefPubMed
32.
go back to reference Snell-Bergeon JK, Nadeau K: J Cardiovascular Disease Risk in Young People with Type 1 Diabetes. Cardiovasc Transl Res. 2012, 5: 446-462. 10.1007/s12265-012-9363-x.CrossRef Snell-Bergeon JK, Nadeau K: J Cardiovascular Disease Risk in Young People with Type 1 Diabetes. Cardiovasc Transl Res. 2012, 5: 446-462. 10.1007/s12265-012-9363-x.CrossRef
33.
go back to reference Giménez M, López JJ, Castell C, Conget I: Hypoglycaemia and cardiovascular disease in Type 1 Diabetes. Results from the Catalan National Public Health registry on insulin pump therapy. Diabetes Res Clin Pract. 2012, 96: e23-e25. 10.1016/j.diabres.2012.01.014.CrossRefPubMed Giménez M, López JJ, Castell C, Conget I: Hypoglycaemia and cardiovascular disease in Type 1 Diabetes. Results from the Catalan National Public Health registry on insulin pump therapy. Diabetes Res Clin Pract. 2012, 96: e23-e25. 10.1016/j.diabres.2012.01.014.CrossRefPubMed
34.
go back to reference Ceriello A, Novials A, Ortega E, Canivell S, La Sala L, Pujadas G, Esposito K, Giugliano D, Genovese S: GLP-1 reduces endothelial dysfunction, inflammation and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care. 2013, Apr 5. [Epub ahead of print] Ceriello A, Novials A, Ortega E, Canivell S, La Sala L, Pujadas G, Esposito K, Giugliano D, Genovese S: GLP-1 reduces endothelial dysfunction, inflammation and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care. 2013, Apr 5. [Epub ahead of print]
Metadata
Title
Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes
Authors
Antonio Ceriello
Anna Novials
Emilio Ortega
Silvia Canivell
Gemma Pujadas
Lucia La Sala
Loredana Bucciarelli
Maurizio Rondinelli
Stefano Genovese
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-97

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.